Cargando…
Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359848/ https://www.ncbi.nlm.nih.gov/pubmed/33656198 http://dx.doi.org/10.1111/jdv.17201 |
_version_ | 1783737621377187840 |
---|---|
author | Fujita, Y. Nohara, T. Takashima, S. Natsuga, K. Adachi, M. Yoshida, K. Shinkuma, S. Takeichi, T. Nakamura, H. Wada, O. Akiyama, M. Ishiko, A. Shimizu, H. |
author_facet | Fujita, Y. Nohara, T. Takashima, S. Natsuga, K. Adachi, M. Yoshida, K. Shinkuma, S. Takeichi, T. Nakamura, H. Wada, O. Akiyama, M. Ishiko, A. Shimizu, H. |
author_sort | Fujita, Y. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8359848 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83598482021-08-17 Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study Fujita, Y. Nohara, T. Takashima, S. Natsuga, K. Adachi, M. Yoshida, K. Shinkuma, S. Takeichi, T. Nakamura, H. Wada, O. Akiyama, M. Ishiko, A. Shimizu, H. J Eur Acad Dermatol Venereol Letters to the Editor John Wiley and Sons Inc. 2021-03-14 2021-08 /pmc/articles/PMC8359848/ /pubmed/33656198 http://dx.doi.org/10.1111/jdv.17201 Text en © 2021 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Letters to the Editor Fujita, Y. Nohara, T. Takashima, S. Natsuga, K. Adachi, M. Yoshida, K. Shinkuma, S. Takeichi, T. Nakamura, H. Wada, O. Akiyama, M. Ishiko, A. Shimizu, H. Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study |
title | Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study |
title_full | Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study |
title_fullStr | Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study |
title_full_unstemmed | Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study |
title_short | Intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study |
title_sort | intravenous allogeneic multilineage‐differentiating stress‐enduring cells in adults with dystrophic epidermolysis bullosa: a phase 1/2 open‐label study |
topic | Letters to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359848/ https://www.ncbi.nlm.nih.gov/pubmed/33656198 http://dx.doi.org/10.1111/jdv.17201 |
work_keys_str_mv | AT fujitay intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT noharat intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT takashimas intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT natsugak intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT adachim intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT yoshidak intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT shinkumas intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT takeichit intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT nakamurah intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT wadao intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT akiyamam intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT ishikoa intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy AT shimizuh intravenousallogeneicmultilineagedifferentiatingstressenduringcellsinadultswithdystrophicepidermolysisbullosaaphase12openlabelstudy |